Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
New Managers January 2013

Launches - A recapitulation of maiden launches in the last 30 days, and related matters

We recently heard of those ex-hedge funders (including a couple from Tudor, a couple from Soros, and a few more from SAC) striking out on their own:

  • Ex-FrontPoint manager Tim Flannery, who ran utility and energy fund Copia Capital, which had to be liquidated in December, is apparently planning a comeback in March.
  • Steve Gross, who was previously portfolio manager at Tudor Investments and before that, partner at Penso Capital Markets and fund manager at Millennium, has just launched AlphaParity in New York and its new fund, the All-Weather Strategy (full Opalesque Exclusive article in AMB and in this publication's Profiles section).
  • Andrew McMillan, Another former portfolio manager at Tudor Investment Corp who oversaw energy investing from Singapore is setting up his own business with five former colleagues. Tudor partners may invest with McMillan when he preps his fund.
  • Imran Hussain, former head of emerging market debt and currency portfolios for BlackRock, quit and partnered with former Octagon Asset Management head portfolio manager Mead Welles to launch a new emerging markets fund in New York called Infineon......................

    To view our full article please login

    This article was published in Opalesque's New Managers a top-down monthly analysis, news and research publication on the global emerging manager space.
    New Managers
    New Managers
    New Managers

  • Today's Exclusives Today's Other Voices More Exclusives
    Previous Opalesque Exclusives                                  
    More Other Voices
    Previous Other Voices                                               
    Access Alternative Market Briefing


    • Top Forwarded
    • Top Tracked
    • Top Searched
    1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

      From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

    2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

      From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

    3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

      Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

    4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

      Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

    5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

      Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

     

    banner